Genetics Used to Treat Neurological Diseases in $622mln Presentation

• Genetics used to treat neurological diseases • Voyager's preclinical and clinical development milestones • Company's potential development candidates • Use of genetic data in drug discovery and development • Precision medicine approach for neurological diseases • Voyager's focus on genetic-based treatments • Potential for genetic data to improve drug efficacy and safety • Voyager's efforts to leverage genetic data for neurological disease treatment • Company's goal of advancing precision medicine for neurological diseases • Genetic data as a key component of Voyager's treatment approach • Voyager's focus on genetic-based treatments for neurological diseases • Use of genetic data to identify potential drug targets • Voyager's efforts to advance genetic-based treatments for neurological diseases • Company's focus on using genetic data to improve drug efficacy and safety • Voyager's approach to treating neurological diseases using genetic data • Genetic data as a key component of Voyager's treatment strategy • Voyager's efforts to leverage genetic data for neurological disease treatment • Company's focus on advancing precision medicine for neurological diseases • Use of genetic data to identify potential drug targets for neurological diseases.